The pharmacist as physician extender in family medicine office practice

Journal of the American Pharmacists Association

Volumn 46, Issue 1, 2006, Pages 77-83

  Nichol, Allen ^a,b,c,d,e   Downs, George E ^f  

^a Diabetes Management Program   (United States)

^b OHIO DEPARTMENT OF HEALTH   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OHIO NORTHERN UNIVERSITY   (United States)

^e UNIVERSITY OF TOLEDO   (United States)

^f UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Diabetes mellitus; Economics; Family medicine; Metabolic syndrome; Pharmaceutical care; Physicians; Work activities

Indexed keywords

ARTICLE; CLINICAL PHARMACY; DIABETES MELLITUS; EXERCISE; FAMILY MEDICINE; FOOT CARE; HUMAN; MEDICAL PRACTICE; METABOLIC SYNDROME X; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; PRIVATE PRACTICE; ADOLESCENT; ADULT; AGED; DISEASE MANAGEMENT; ECONOMICS; EDUCATION; ETHNIC GROUP; FEMALE; GENERAL PRACTICE; HEALTH CARE FACILITY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGANIZATION AND MANAGEMENT; PHARMACY; REIMBURSEMENT; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; EDUCATION, PHARMACY; ETHNIC GROUPS; FAMILY PRACTICE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACISTS; PHYSICIANS' OFFICES; REIMBURSEMENT MECHANISMS;

EID: 33645504403     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434506775268599     Document Type: Article

References (24)

1. Kuo GM, Buckley TE, Fitzsimmons DS, et al. Collaborative drug therapy management services and reimbursement in a family medicine clinic. Am J Health Syst Pharm. 2004;61:343-54.
2. McDonough RP, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc. 2003;41:682-92.
3. Carter BL, Chrischilles EA, Scholz D, et al. Extent of services provided by pharmacists in the Iowa Medicaid pharmaceutical care management program. J Am Pharm Assoc. 2003;43:24-33.
4. Cranor CW, Christensen DB. The Asheville project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
5. Cranor CW, Christensen DB. The Asheville project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:160-72.
6. Cranor CW, Bunting BA, Christensen DB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
7. Howard M, Trim K, Woodward C, et al. Collaboration between community pharmacist and family physicians: lessons learning from the seniors medication assessment research trial. J Am Pharm Assoc. 2003;43:565-72.
8. Ernst M, Brandt KB. Evaluation of 4 years of clinical pharmacist anticoagulation care management in a rural private physicians office. J Am Pharm Assoc. 2003;43:630-6.
9. Campbell RK, Saulie BA. Providing pharmaceutical care in a physician office. J Am Pharm Assoc. 1998;38:495-9.
10. Sias JJ, Bennett MS, A reimbursable education service for patients with hepatitis C. J Am Pharm Assoc. 2001;41:448-53.
11. Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J. 2003;169:17-22.
12. National Heart, Lung and Blood Institute. National cholesterol education program-ATP guidelines III, goals and treatment review. General features of the metabolic syndrome. Accessed at http://hin.nhlbi. nih.gov/ncep_slds/atpiii/ slide42.htm, February 2, 2004.
13. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (position statement). Diabetes Care. 2002;25:S33-S49.
14. American Diabetes Association. 2004 clinical practice recommendation. Accessed at http://care.diabetesjournals.org/content/vol27/suppl_1/, February 2, 2004.
15. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27:2444-9.
16. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 291;3:335-42.
17. National Institutes of Health, National Heart Lung and Blood Institute. Third report of the National Cholesterol Education Program (NCEP) on the detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Bethesda, Md.: National Institutes of Health; 2002. NIH Publication 02-5215. Accessed at www.nhlbi.nih.gov/guideslines/cholesterol, February 2, 2004.
18. National Institutes of Health, National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Accessed at www.nhlbi.nih.gov/ guidelines/obesity/ob_home.htm, February 2, 2004.
19. National Institutes of Health, National Heart, Lung and Blood Institute. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Accessed at www.nhlbi.nih.gov/guidelines/hypertension/index.htm, February 2, 2004.
20. National Center for Health Statistics. NHANES current data files. Accessed at www.cdc.gov/nchs/about/major/nhanes/nhanes99-02.htm. October 19, 2004.
21. American Medical Association. Current procedural terminology (CPT) 2006. Chicago: American Medical Association; 2006.
22. Snella KA, Sachdev GP. A primer for developing pharmacist-managed clinics in the outpatient setting. Pharmacotherapy. 2003;23:1153-66.
23. Snella KA, Trewyn RR, Hansen LB, Bradberry JC. Pharmacist compensation for cognitive services: focus on the physician office and community pharmacy. Pharmacotherapy. 2004;24:372-88.
24. Ganther JM. Third party reimbursement for pharmacists services: why has it been so difficult to obtain and is it really the answer to pharmacy? J Am Pharm Assoc. 2002;42:875-9.